Stinginn, LLC
Advertisement
STINGINN, LLC, based in Miami, FL, is dedicated to harnessing the innate immune system to address challenges in infectious disease, inflammation, and cancer. Founded on the discoveries of Glen N. Barber, the company focuses on the STING-controlled innate immune pathway, which plays a critical role in regulating cytokine production essential for fighting infections and generating anti-tumor immunity.
The firm has developed a robust portfolio of therapeutics aimed at modulating STING signaling, with applications in anti-cancer immunotherapy and anti-inflammatory treatments. Among its innovations are STING activators and proprietary assays designed to identify novel compounds, as well as a vaccine candidate targeting the Human T-cell Lymphotropic Virus type-1 (HTLV-1), showcasing STINGINN's commitment to advancing clinical solutions for significant health issues.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement